Why Does My Patient Have Lymphadenopathy or Splenomegaly?

Hematology/Oncology Clinics of North America

Volumn 26, Issue 2, 2012, Pages 395-408

  Motyckova, Gabriela ^a   Steensma, David P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Differential diagnosis; Hematological malignancy; Lymphadenopathy; Splenomegaly

Indexed keywords

AMYLOIDOSIS; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BLOOD CELL COUNT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EXTRAMEDULLARY HEMATOPOIESIS; GRANULOMATOSIS; HEAD AND NECK CANCER; HEMOLYSIS; HUMAN; HYPERSPLENISM; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTOZOAL INFECTION; REVIEW; SARCOIDOSIS; SEROLOGY; SPLEEN BIOPSY; SPLENECTOMY; SPLENOMEGALY; STORAGE DISEASE; VIRUS INFECTION;

BIOPSY; HUMANS; LYMPH NODES; LYMPHATIC DISEASES; SPLENECTOMY; SPLENOMEGALY;

EID: 84859051674     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.02.005     Document Type: Review

References (70)

1. Herzog L.W. Prevalence of lymphadenopathy of the head and neck in infants and children. Clin Pediatr (Phila) 1983, 22(7):485-487.
2. McIntyre O.R., Ebaugh F.G. Palpable spleens in college freshmen. Ann Intern Med 1967, 66(2):301-306.
3. Ebaugh F.G., McIntyre O.R. Palpable spleens: ten-year follow-up. Ann Intern Med 1979, 90(1):130-131.
4. Henry M., Kamat D. Integrating basic science into clinical teaching initiative series: approach to lymphadenopathy. Clin Pediatr (Phila) 2011, 50(8):683-687.
5. Friedmann A.M. Evaluation and management of lymphadenopathy in children. Pediatr Rev 2008, 29(2):53-60.
6. Libman H. Generalized lymphadenopathy. J Gen Intern Med 1987, 2(1):48-58.
7. Greiner T., Armitage J.O., Gross T.G. Atypical lymphoproliferative diseases. Hematology Am Soc Hematol Educ Program 2000, 133-146.
8. Sallah S., Gagnon G.A. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haematol 1998, 99(2):57-64.
9. McClain K.L., Natkunam Y., Swerdlow S.H. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program 2004, 283-296.
10. Prignano F., D'Erme A.M., Zanieri F., et al. Why is Kikuchi-Fujimoto disease misleading. Int J Dermatol 2011, [Epub ahead of print].
11. Habermann T.M., Steensma D.P. Lymphadenopathy. Mayo Clin Proc 2000, 75(7):723-732.
12. Mohan A., Reddy M.K., Phaneendra B.V., et al. Aetiology of peripheral lymphadenopathy in adults: analysis of 1724 cases seen at a tertiary care teaching hospital in southern India. Natl Med J India 2007, 20(2):78-80.
13. Nikanne E., Ruoppi P., Vornanen M. Kikuchi's disease: report of three cases and an overview. Laryngoscope 1997, 107(2):273-276.
14. Norris A.H., Krasinskas A.M., Salhany K.E., et al. Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. Am J Med 1996, 101(4):401-405.
15. Tsang W.Y., Chan J.K. Fine-needle aspiration cytologic diagnosis of Kikuchi's lymphadenitis. A report of 27 cases. Am J Clin Pathol 1994, 102(4):454-458.
16. Tsang W.Y., Chan J.K., Ng C.S. Kikuchi's lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol 1994, 18(3):219-231.
17. Khanna R., Sharma A.D., Khanna S., et al. Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy. World J Surg Oncol 2011, 9:29.
18. Kim B.M., Kim E.K., Kim M.J., et al. Sonographically guided core needle biopsy of cervical lymphadenopathy in patients without known malignancy. J Ultrasound Med 2007, 26(5):585-591.
19. Lai K.K., Stottmeier K.D., Sherman I.H., et al. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA 1984, 251(10):1286-1288.
20. Steinkamp H.J., Cornehl M., Hosten N., et al. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol 1995, 68(807):266-270.
21. Steinkamp H.J., Maurer J., Cornehl M., et al. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol 1994, 251(7):404-409.
22. Sumi M., Ohki M., Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 2001, 176(4):1019-1024.
23. Wu C.H., Chang Y.L., Hsu W.C., et al. Usefulness of Doppler spectral analysis and power Doppler sonography in the differentiation of cervical lymphadenopathies. AJR Am J Roentgenol 1998, 171(2):503-509.
24. Ying M., Ahuja A., Metreweli C. Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy. J Ultrasound Med 1998, 17(7):437-445.
25. Ying M., Ahuja A.T., Evans R., et al. Cervical lymphadenopathy: sonographic differentiation between tuberculous nodes and nodal metastases from non-head and neck carcinomas. J Clin Ultrasound 1998, 26(8):383-389.
26. Knopf A., Bas M., Chaker A., et al. Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 2011, 50(11):2029-2034.
27. Morgenstern L. The Virchow-Troisier node: a historical note. Am J Surg 1979, 138(5):703.
28. Shipchandler T.Z., Lorenz R.R., McMahon J., et al. Supraclavicular lymphadenopathy due to silicone breast implants. Arch Otolaryngol Head Neck Surg 2007, 133(8):830-832.
29. Yong H.S., Woo O.H., Lee J.W., et al. Primary localized amyloidosis manifested as supraclavicular and mediastinal lymphadenopathy. Br J Radiol 2007, 80(955):e131-e133.
30. Olsen K.D., DeSanto L.W., Pearson B.W. Positive Delphian lymph node: clinical significance in laryngeal cancer. Laryngoscope 1987, 97(9):1033-1037.
31. Copeland E.M., McBride C.M. Axillary metastases from unknown primary sites. Ann Surg 1973, 178(1):25-27.
32. de Andrade J.M., Marana H.R., Sarmento Filho J.M., et al. Differential diagnosis of axillary masses. Tumori 1996, 82(6):596-599.
33. Kobayashi O., Sugiyama Y., Konishi K., et al. Solitary metastasis to the left axillary lymph node after curative gastrectomy in gastric cancer. Gastric Cancer 2002, 5(3):173-176.
34. Sharma A., Fidias P., Hayman L.A., et al. Patterns of lymphadenopathy in thoracic malignancies. Radiographics 2004, 24(2):419-434.
35. Winterbauer R.H., Belic N., Moores K.D. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973, 78(1):65-71.
36. Glazer G.M., Gross B.H., Quint L.E., et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985, 144(2):261-265.
37. Kiyono K., Sone S., Sakai F., et al. The number and size of normal mediastinal lymph nodes: a postmortem study. AJR Am J Roentgenol 1988, 150(4):771-776.
38. Dorfman R.E., Alpern M.B., Gross B.H., et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991, 180(2):319-322.
39. Einstein D.M., Singer A.A., Chilcote W.A., et al. Abdominal lymphadenopathy: spectrum of CT findings. Radiographics 1991, 11(3):457-472.
40. Abu-Hilal M., Newman J.S. Sister Mary Joseph and her nodule: historical and clinical perspective. Am J Med Sci 2009, 337(4):271-273.
41. Selby C.D., Marcus H.S., Toghill P.J. Enlarged epitrochlear lymph nodes: an old physical sign revisited. J R Coll Physicians Lond 1992, 26(2):159-161.
42. Zaren H.A., Copeland E.M. Inguinal node metastases. Cancer 1978, 41(3):919-923.
43. Wapnick S., MacKintosh M., Mauchaza B. Shoelessness, enlarged femoral lymph nodes, and femoral hernia. A possible association. Am J Surg 1973, 126(1):108-110.
44. Chau I., Kelleher M.T., Cunningham D., et al. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer 2003, 88(3):354-361.
45. Pruzanski W. Lymphadenopathy associated with dysgammaglobulinemia. Semin Hematol 1980, 17(1):44-62.
46. Lee Y., Terry R., Lukes R.J. Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol 1980, 14(1):53-60.
47. Pangalis G.A., Vassilakopoulos T.P., Boussiotis V.A., et al. Clinical approach to lymphadenopathy. Semin Oncol 1993, 20(6):570-582.
48. Baron B.W., Baron J.M. The diagnostic value of biopsy of small peripheral lymph nodes in patients with suspected lymphoma. Am J Hematol 2011, [Epub ahead of print].
49. Gupta A.K., Nayar M., Chandra M. Reliability and limitations of fine needle aspiration cytology of lymphadenopathies. An analysis of 1,261 cases. Acta Cytol 1991, 35(6):777-783.
50. Margolis I.B., Matteucci D., Organ C.H. To improve the yield of biopsy of the lymph nodes. Surg Gynecol Obstet 1978, 147(3):376-378.
51. Sinclair S., Beckman E., Ellman L. Biopsy of enlarged, superficial lymph nodes. JAMA 1974, 228(5):602-603.
52. Pinkus G.S. Needle biopsy in malignant lymphoma. J Clin Oncol 1996, 14(9):2415-2416.
53. Ben-Yehuda D., Polliack A., Okon E., et al. Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol 1996, 14(9):2431-2434.
54. Pappa V.I., Hussain H.K., Reznek R.H., et al. Role of image-guided core-needle biopsy in the management of patients with lymphoma. J Clin Oncol 1996, 14(9):2427-2430.
55. de Kerviler E., de Bazelaire C., Mounier N., et al. Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. Eur Radiol 2007, 17(3):843-849.
56. de Larrinoa A.F., del Cura J., Zabala R., et al. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma. J Clin Ultrasound 2007, 35(6):295-301.
57. Suh Y.J., Kim M.J., Kim J., et al. Tumor markers in fine-needle aspiration washout for cervical lymphadenopathy in patients with known malignancy: preliminary study. AJR Am J Roentgenol 2011, 197(4):W730-W736.
58. Tefferi A. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2011, 86(12):1017-1026.
59. Tefferi A., Vainchenker W. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 2011, 29(5):573-582.
60. vom Dahl S., Mengel E. Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly. Best Pract Res Clin Gastroenterol 2010, 24(5):619-628.
61. Grover S.A., Barkun A.N., Sackett D.L. The rational clinical examination. Does this patient have splenomegaly?. JAMA 1993, 270(18):2218-2221.
62. Berris B. The incidence of palpable liver and spleen in the postpartum period. Can Med Assoc J 1966, 95(25):1318-1319.
63. Benter T., Kluhs L., Teichgraber U. Sonography of the spleen. J Ultrasound Med 2011, 30(9):1281-1293.
64. Prassopoulos P., Daskalogiannaki M., Raissaki M., et al. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 1997, 7(2):246-248.
65. Bezerra A.S., D'Ippolito G., Faintuch S., et al. Determination of splenomegaly by CT: is there a place for a single measurement?. AJR Am J Roentgenol 2005, 184(5):1510-1513.
66. Stark D.D., Moss A.A., Goldberg H.I. Nuclear magnetic resonance of the liver, spleen, and pancreas. Cardiovasc Intervent Radiol 1986, 8(5-6):329-341.
67. Lee J., Kim K.W., Lee H., et al. Semiautomated spleen volumetry with diffusion-weighted MR imaging. Magn Reson Med 2011, [Epub ahead of print].
68. Mesa R.A. How I treat symptomatic splenomegaly in patients with myelofibrosis. Blood 2009, 113(22):5394-5400.
69. Koshenkov V.P., Nemeth Z.H., Carter M.S. Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 2011, [Epub ahead of print].
70. Lavu H. The feasibility and safety of laparoscopic splenectomy for massive splenomegaly: a comparative study. J Surg Res 2011, [Epub ahead of print].